---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284595075.md"
description: "OSR Holdings shares are trading lower after the company announced a license agreement for its VXM01 immunotherapy that includes up to $815 million in milestone payments."
datetime: "2026-04-29T14:04:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284595075.md)
  - [en](https://longbridge.com/en/news/284595075.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284595075.md)
---

# 

OSR Holdings shares are trading lower after the company announced a license agreement for its VXM01 immunotherapy that includes up to $815 million in milestone payments.

### Related Stocks

- [OSRHW.US](https://longbridge.com/en/quote/OSRHW.US.md)
- [OSRH.US](https://longbridge.com/en/quote/OSRH.US.md)

## Related News & Research

- [OSR Health unveils shareholder loyalty plan offering free shares via price-linked CVRs](https://longbridge.com/en/news/290832256.md)
- [Does BioMarin (BMRN) Expanding Into ReNU Syndrome Refine Its Rare Disease Pipeline Strategy?](https://longbridge.com/en/news/294318968.md)
- [Is HCI Group (HCI) Undervalued On Its Zacks Rank #1 Upgrade?](https://longbridge.com/en/news/293829358.md)
- [FDA AdCom shuns Capricor’s DMD cell therapy amid data dispute](https://longbridge.com/en/news/294380808.md)
- [10:02 ETNew Luxury Cosmetic Surgery Practice Arrives at Lotis Wellington on State Road 7](https://longbridge.com/en/news/294079011.md)